Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology's 70th Annual Scientific Session Biotech Investing
Medtronic Announces CE Mark of Evolut PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe Medical Device Investing
Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE for Treatment of Macular Edema Associated with Uveitis Medical Device Investing
Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO Medical Device Investing
Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities Psychedelics Investing
Merck Hosts Organon Investor Day Outlining New Company's Vision, Focus and Business Model for Sustained Growth Pharmaceutical Investing
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
Perimeter Medical Imaging AI Reports 2020 Financial Results and Provides Corporate Update Medical Device Investing
BLU Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
